The Net Margin of Invex Therapeutics Ltd (IXC.AX) is -96.35%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-06-30 | -96.35% |
| 2023-06-30 | -616.94% |
| 2022-06-30 | -1508.08% |
| 2021-06-30 | -1438.32% |
| 2020-06-30 | -2027.93% |
| 2019-06-30 | -178553.85% |